SEC Form 4 · accession 0001645627-18-000016
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Mar 19, 2018
Accepted (ET)
Mar 23, 2018 · 5:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 19, 2018 | P | 1,000 | $0.037 | A | 24,881,689 | D | |
| Common Stock | Mar 19, 2018 | P | 1,000 | $0.0366 | A | 24,882,689 | D | |
| Common Stock | Mar 19, 2018 | P | 1,000 | $0.037 | A | 24,883,689 | D | |
| Common Stock | Mar 19, 2018 | P | 1,000 | $0.037 | A | 24,884,689 | D | |
| Common Stock | Mar 20, 2018 | P | 1,000 | $0.0366 | A | 24,885,689 | D | |
| Common Stock | Mar 20, 2018 | P | 1,000 | $0.0369 | A | 24,886,689 | D | |
| Common Stock | Mar 20, 2018 | P | 1,000 | $0.0368 | A | 24,887,689 | D | |
| Common Stock | Mar 20, 2018 | P | 1,000 | $0.0369 | A | 24,888,689 | D | |
| Common Stock | Mar 21, 2018 | P | 1,000 | $0.037 | A | 24,889,689 | D | |
| Common Stock | Mar 21, 2018 | P | 1,000 | $0.037 | A | 24,890,689 | D | |
| Common Stock | Mar 21, 2018 | P | 1,000 | $0.0374 | A | 24,891,689 | D |
Table II — derivative securities
No Table II lines on this filing.